BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22100027)

  • 1. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Kaya MG; Uyarel H; Akpek M; Kalay N; Ergelen M; Ayhan E; Isik T; Cicek G; Elcik D; Sahin O; Cosgun SM; Oguzhan A; Eren M; Gibson CM
    Am J Cardiol; 2012 Feb; 109(4):486-91. PubMed ID: 22100027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
    Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
    Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between γ-glutamyl transferase levels and the clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Gul M; Uyarel H; Ergelen M; Ekmekci A; Ozal E; Murat A; Kul S; Celik O; Karaca G; Akturk F; Eksik A
    Coron Artery Dis; 2013 Jun; 24(4):272-8. PubMed ID: 23542158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lindberg S; Pedersen SH; Møgelvang R; Bjerre M; Frystyk J; Flyvbjerg A; Galatius S; Jensen JS
    Am J Cardiol; 2012 Feb; 109(4):492-6. PubMed ID: 22105783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
    Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
    Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major adverse upper gastrointestinal events in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention and dual antiplatelet therapy.
    Chen YL; Chang CL; Chen HC; Sun CK; Yeh KH; Tsai TH; Chen CJ; Chen SM; Yang CH; Hang CL; Wu CJ; Yip HK
    Am J Cardiol; 2011 Dec; 108(12):1704-9. PubMed ID: 21924391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Percutaneous coronary revascularization in patients over eighty: acute and long-term results].
    Lettieri C; Buffoli F; Romano M; Aroldi M; Baccaglioni N; Tomasi L; Rosiello R; Agostini F; Kuwornu H; Pepi P; Izzo A; Zanini R
    Ital Heart J Suppl; 2005 Sep; 6(9):588-98. PubMed ID: 16281718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of female sex on long-term outcomes in patients with ST-elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ferrante G; Corrada E; Belli G; Zavalloni D; Scatturin M; Mennuni M; Gasparini GL; Bernardinelli L; Cianci D; Pastorino R; Rossi ML; Pagnotta P; Presbitero P
    Can J Cardiol; 2011; 27(6):749-55. PubMed ID: 21924580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction.
    D'Ascenzo F; Gonella A; Quadri G; Longo G; Biondi-Zoccai G; Moretti C; Omedè P; Sciuto F; Gaita F; Sheiban I
    Am J Cardiol; 2011 Mar; 107(5):651-4. PubMed ID: 21195375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
    Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
    Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.
    Gul M; Uyarel H; Ergelen M; Akgul O; Karaca G; Turen S; Ugur M; Ertürk M; Kul S; Surgit O; Bozbay M; Uslu N
    Am J Cardiol; 2013 Jan; 111(2):166-71. PubMed ID: 23102877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Hoebers LP; Damman P; Claessen BE; Vis MM; Baan J; van Straalen JP; Fischer J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Am J Cardiol; 2012 Jan; 109(1):53-9. PubMed ID: 21944676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
    Wolfram RM; Brewer HB; Xue Z; Satler LF; Pichard AD; Kent KM; Waksman R
    Am J Cardiol; 2006 Sep; 98(6):711-7. PubMed ID: 16950168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.